Fenofibrate - from cholesterol to gout?

Nissen, Lisa M. (2011) Fenofibrate - from cholesterol to gout?. Australian Pharmacist, 30 8: 643-643.

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
AustPharm_Fenofibrate.pdf AustPharm_Fenofibrate.pdf application/pdf 201.85KB 41
Author Nissen, Lisa M.
Title Fenofibrate - from cholesterol to gout?
Journal name Australian Pharmacist   Check publisher's open access policy
ISSN 0728-4632
Publication date 2011-08
Sub-type Critical review of research, literature review, critical commentary
Open Access Status File (Author Post-print)
Volume 30
Issue 8
Start page 643
End page 643
Total pages 1
Place of publication Australia
Publisher Pharmaceutical Society of Australia
Collection year 2012
Language eng
Abstract Gout is a common form of arthritis effecting around 70,000 Australians. It is characterised by recurrent acute attacks of pain, swelling and redness that most commonly affects the joints in the big toe, but gout may also be experienced in the feet, ankles, knees, and less commonly in the elbows, hands and other joints. The symptoms of gout include, intense joint pain (most severe within the first 12 to 24 hours), lingering discomfort (may last days to weeks) and inflammation and redness (with swollen, tender and red joints).
Q-Index Code CX
Q-Index Status Confirmed Code
Institutional Status UQ
Additional Notes old drug new indication

Document type: Journal Article
Sub-type: Critical review of research, literature review, critical commentary
Collections: Non HERDC
School of Pharmacy Publications
 
Versions
Version Filter Type
Citation counts: Google Scholar Search Google Scholar
Created: Thu, 29 Sep 2011, 14:16:19 EST by Charna Kovacevic on behalf of School of Pharmacy